A61K 39/095
Neisseria
A61K39/095 (Neisseria) appears on 520 US grants and 765 published applications in this corpus.
Search patents in A61K- Granted patents
- 520
- Published applications
- 765
- Assignees
- 258
- Inventors
- 1,033
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 2 |
| 2002 | 6 | 11 |
| 2003 | 8 | 13 |
| 2004 | 5 | 16 |
| 2005 | 6 | 17 |
| 2006 | 8 | 30 |
| 2007 | 7 | 27 |
| 2008 | 5 | 37 |
| 2009 | 11 | 44 |
| 2010 | 16 | 40 |
| 2011 | 14 | 40 |
| 2012 | 20 | 51 |
| 2013 | 25 | 46 |
| 2014 | 26 | 34 |
| 2015 | 37 | 42 |
| 2016 | 42 | 46 |
| 2017 | 39 | 43 |
| 2018 | 28 | 38 |
| 2019 | 35 | 33 |
| 2020 | 29 | 28 |
| 2021 | 26 | 25 |
| 2022 | 8 | 25 |
| 2023 | 20 | 23 |
| 2024 | 13 | 23 |
| 2025 | 17 | 17 |
| 2026 | 8 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines11 Aug 2026US 12,702,705 B2Glaxosmithkline Biologicals SA
- Outer membrane vesicles16 Jun 2026US 12,653,879 B2Glaxosmithkline Biologicals SA
- Multi-antigenic peptide mimics of gonococcal lipo-oligosaccharide (LOS) epitopes19 May 2026US 12,629,410 B2University of Massachusetts
- Neisseria meningitidis vaccine28 Apr 2026US 12,611,451 B2Sanofi Vaccines US Inc.
- Neisseria gonorrhoeae vaccine compositions and methods of selecting antigens14 Apr 2026US 12,599,655 B2Trustees of Tufts College
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Composition24 Sep 2026US 2026/0284171 A1Oxford University Innovation Limited
- Immunogenic composition10 Sep 2026US 2026/0263578 A1Glaxosmithkline Biologicals SA
- Immunogenic composition10 Sep 2026US 2026/0263579 A1Glaxosmithkline Biologicals SA
- Immunogenic protein against gonococcal infection20 Aug 2026US 2026/0242425 A1Griffith University
Most cited
By later US patents
- Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease195US 4,601,903 AThe United States of America as represented by the Department of Health and Human Services · 1986
- Pneumococcal polysaccharide conjugate vaccine98US 5,623,057 AMerck & Co., Inc. · 1997
- Method for the covalent attachment of polysaccharides to protein molecules80US 5,965,714 AConnaught Laboratories Limited · 1999
- Neisseria meningitidis antigens and compositions80US 7,576,176 B1Novartis Vaccines and Diagnostics, Inc. · 2009
- Modified meningococcal group B polysaccharide for conjugate vaccine77US 4,727,136 ACanadian Patents and Development Limited · 1988